Semax
Batch #010010 · Research use only.
High-purity research-grade Semax
Semax is a synthetic peptide derived from the ACTH(4-10) fragment and is widely studied for its neuroprotective and nootropic properties, especially around focus, memory, and recovery from neurological stressors. It is commonly explored in research settings for its potential to modulate key neurotransmitters and upregulate brain-derived neurotrophic factor (BDNF), supporting cognitive performance and brain resilience.
Product overview
Semax is a research peptide modeled on the adrenocorticotropic hormone (ACTH) 4-10 sequence (Met-Glu-His-Phe-Pro-Gly-Pro), engineered for enhanced stability and resistance to enzymatic breakdown. Preclinical and clinical research associates Semax with nootropic, neuroprotective, anxiolytic, and neuroregenerative effects in various models of ischemia, stress, and cognitive impairment.
Key research features
Supports cognitive function: Studies indicate Semax may enhance learning, memory formation, attention, and mental clarity, particularly under high cognitive demand or neurological stress. These effects are thought to be mediated by modulation of neurotransmitter systems and improved cerebral blood flow.
Neuroprotective properties: Research suggests Semax can reduce oxidative stress, downregulate pro‑inflammatory cytokines, and protect neurons during ischemic or hypoxic conditions. This profile makes it a prominent candidate in experimental models of stroke and traumatic brain injury recovery.
Mood and stress modulation: By influencing dopaminergic and serotonergic pathways, Semax has been investigated for its potential to support mood stability, stress resilience, and anxiety reduction. Early work also points to possible utility in conditions such as ADHD and Rett syndrome.
Semax Suggested Use:
Typical Dose: 300–600 mcg per day
Route: Intranasal
Frequency: 1–3 times daily
Duration: 4–6 weeks, or as recommended by a healthcare professional